Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Berger

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|August 1, 1982
Alcohol and the borderline personalityG E Berger
Molecular Psychiatry|April 6, 2006
The role of phospholipases A2 in schizophreniaM H Law, R G H Cotton, G E Berger
Clinical Chemistry|March 1, 1993
Cocaine and benzoylecgonine in saliva, serum, and urineW Schramm, P A Craig, R H Smith, et al.
Schizophrenia Research|May 9, 2006
Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individualsG P Amminger, S Leicester, A R Yung, et al.
Schizophrenia Research|June 12, 2009
Pituitary volume and early treatment response in drug-naïve first-episode psychosis patientsB Garner, G E Berger, J P Nicolo, et al.
Molecular Psychiatry|March 13, 2013
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosisS Smesny, B Milleit, U-C Hipler, et al.
Schizophrenia Research|April 20, 2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?H Hadar, H Zhang, L J Phillips, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|August 1, 1982
Alcohol and the borderline personalityG E Berger
Molecular Psychiatry|April 6, 2006
The role of phospholipases A2 in schizophreniaM H Law, R G H Cotton, G E Berger
Clinical Chemistry|March 1, 1993
Cocaine and benzoylecgonine in saliva, serum, and urineW Schramm, P A Craig, R H Smith, et al.
Schizophrenia Research|May 9, 2006
Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individualsG P Amminger, S Leicester, A R Yung, et al.
Schizophrenia Research|June 12, 2009
Pituitary volume and early treatment response in drug-naïve first-episode psychosis patientsB Garner, G E Berger, J P Nicolo, et al.
Molecular Psychiatry|March 13, 2013
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosisS Smesny, B Milleit, U-C Hipler, et al.
Schizophrenia Research|April 20, 2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?H Hadar, H Zhang, L J Phillips, et al.
Pageof 1